chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The Pfizer covid vaccine improved my hearing and lessened my tinnitus; The Pfizer covid vaccine improved my hearing and lessened my tinnitus; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP), Program ID: The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "The Pfizer COVID vaccine IMPROVED my hearing and LESSENED my tinnitus" (unspecified if ongoing); "The Pfizer COVID vaccine IMPROVED my hearing and LESSENED my tinnitus" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), PRE-EXISTING CONDITION IMPROVED (non-serious), outcome "unknown" and all described as "The pfizer covid vaccine improved my hearing and lessened my tinnitus".  Additional information: The Pfizer COVID vaccine IMPROVED my hearing and LESSENED my tinnitus. I know there is research happening regarding an alleged cause of tinnitus from the vaccine because of perceived prevalence, but my experience was the exact opposite. I have tinnitus because of a TBI, and the initial research seems to connect the neurological effects of COVID with the vaccine's alleged effect on tinnitus. It had the opposite effect on me. I'm not sure how to get that information to the right researchers.  Follow-up attempts are completed. No further information is expected.
Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Medium, Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Mild
With no prior injury toe on right foot  became swollen and red, similar to chilblains. Showing signs of improvent as of June 16th.
mom states pt recv vax 10 or 11AM & shortly p/vax devel chills, h/a & vomiting;came home from school T98.6 according to mom;feel bad immed p/vax;
Body temperature dropping; Coldness; This spontaneous case was reported by a consumer and describes the occurrence of BODY TEMPERATURE DECREASED (Body temperature dropping) and FEELING COLD (Coldness) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced BODY TEMPERATURE DECREASED (Body temperature dropping) and FEELING COLD (Coldness). On 03-Mar-2021, BODY TEMPERATURE DECREASED (Body temperature dropping) and FEELING COLD (Coldness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       no concomitant medications and treatment medications were provided.   This case was linked to MOD-2021-372771 (Patient Link).   Reporter did not allow further contact
Woke up with a consistent ringing in both ears (4:00 am Monday 3/29/2021 - vaccine received 11:50 am  Saturday 3/27/2021)  No previous history of tinnitus or hearing loss.
pt recvd vax & an inj site rxn characterized by itch, pain, swelling & inflammation w/in 24hrs post inj;the inflamed area was as large as silver dollar coin;pt also exp chills & fever;
Injection at 2:00 PM, 11/14/03. Rash appeared on legs 11/15/03 in morning. Rash worsened on legs Saturday; not seen Urgent care. Rash continued to intensify; legs, feet began to swell. Sunday: rash spread to torso. Seen in ER 11/16/03 (skin swollen around hands/welts). Hospitalization 11/16/03. The follow up received on 1/2/04 states Henoch-Schonlein purpura vasculitis.
I contracted COVID after a family vacation. (Interestingly, three  of our four family members tested positive and were symptomatic.  All four of us had received three Covid vaccines.  The fourth never tested positive -despite sharing food, drinks, sleeping in close quarters, etc.)   I tested positive with a home test.  Symptoms were sore throat, cough, fever, tiredness, headache.  I called my doctor's office and was prescribed Paxlovid.  I finished the entire course.  I tested positive for a total of 10 days, but felt much better around day 7 or 8.
Patient came in to get first dose of Pediatric Pfizer and the medication didn't get diluted properly.
Around 1-2am I developed a fever and chills associated with moderate diffuse myalgia, arthralgia in my left elbow strangely enough (injection was in right deltoid), and fatigue. My symptoms were constant until around 1pm when I took 500mg Tylenol.   Of note, I had COVID in March 2020.
Local reaction with induration and surrounding erythema, pruritus and tenderness. Developed 2 days post vaccination. Treated with antihistamine, cold packs, PO antibiotics to cover possible cellulitis (L) arm.
Dizziness; unable to read labels; Inability to use any limbs including neck; could not talk; weakness; blood pressure low; blood sugar low; Sudden urge to urinate; Vision blurriness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), VISUAL IMPAIRMENT (unable to read labels), MOVEMENT DISORDER (Inability to use any limbs including neck), SPEECH DISORDER (could not talk) and ASTHENIA (weakness) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045A20A and 042?21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Bipolar affective disorder. Concurrent medical conditions included Drug allergy (Bactrim, baclofen) and Penicillin allergy. Concomitant products included CLONAZEPAM (KLONOPIN) for Anxiety, TRAZODONE HYDROCHLORIDE (TRAZODONE) for Depression, LAMOTRIGINE (LAMICTAL) for Mood change, QUETIAPINE FUMARATE (SEROQUEL) for Psychosis, LISDEXAMFETAMINE MESILATE (VYVANSE) and MIRTAZAPINE for an unknown indication.   On 24-Mar-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced DIZZINESS (Dizziness), VISUAL IMPAIRMENT (unable to read labels), MOVEMENT DISORDER (Inability to use any limbs including neck), SPEECH DISORDER (could not talk), ASTHENIA (weakness), HYPOTENSION (blood pressure low), BLOOD GLUCOSE DECREASED (blood sugar low), MICTURITION URGENCY (Sudden urge to urinate), VISION BLURRED (Vision blurriness) and FATIGUE (Fatigue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 23-Mar-2021, DIZZINESS (Dizziness), VISUAL IMPAIRMENT (unable to read labels), MOVEMENT DISORDER (Inability to use any limbs including neck), SPEECH DISORDER (could not talk), ASTHENIA (weakness), HYPOTENSION (blood pressure low), BLOOD GLUCOSE DECREASED (blood sugar low), MICTURITION URGENCY (Sudden urge to urinate), VISION BLURRED (Vision blurriness) and FATIGUE (Fatigue) had resolved. Not Provided          This case was linked to MOD-2021-104721, MOD-2021-104721 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Second dose details and outcome of events after first dose, Concomitant medications with indication added
Patient originally received 1 dose of Moderna on 03/05/2021. Patient presented today for second dose of Moderna, but was given a dose of Pfizer instead by vaccinator.
About 1 week after the MMR injection, the pt developed swelling and burning pain followed by numbness at times and a shooting pain down his arm, which can extended to his hand.
Swelling under my arm after my vaccine; pain under my arm after my vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling under my arm after my vaccine) and MYALGIA (pain under my arm after my vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (Swelling under my arm after my vaccine) and MYALGIA (pain under my arm after my vaccine). At the time of the report, SWELLING (Swelling under my arm after my vaccine) and MYALGIA (pain under my arm after my vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided.  No treatment details were provided.   Reporter did not allow further contact
foggy mental clarity issues ongoing, breathing issues ongoing, periodic headaches, easy bruising with very dark purple coloring
chills, fever, unusual tiredness w/excessive sleepiness, pain, tenderness, swelling @ site of inj (12cm induration & redness & h/a cont p/72hr);
7/19 13:00:  Around 1255 patient was in the dinning room for lunch and staff called for nursing to come and check him out. Patient was sitting at the table slumped down in his chair, this nurse asked staff to try and sit him up at the table. Patient had his spoon in his hand and seemed to have difficulty getting the spoon into the separated plate to get some food but was experiencing extra arm movement which was making it difficult for him. This nurse went to the NS and asked Dr. to come and see patient. Staff brought him to the NS where patient got his VS taken and Dr. performed her assessment and at that time decided to have him sent to the ER. (ataxia, ballistic movements, inability to walk, inability to feed oneself, hand coordination poor)
Unusual high blood pressure; Chills; Tired; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Unusual high blood pressure), CHILLS (Chills) and FATIGUE (Tired) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), BENAZEPRIL, AMLODIPINE and POTASSIUM for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced HYPERTENSION (Unusual high blood pressure), CHILLS (Chills) and FATIGUE (Tired). At the time of the report, HYPERTENSION (Unusual high blood pressure), CHILLS (Chills) and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 149/94 mmHg (High) 149/94 and 120/71 mmHg (normal) 120/71.         Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant and treatment information not provided
Immediate tachycardia  double resting heart rate   lasting about 1 1/2 hours  Mild itching no rash  Chest tightness without shortness of breath approximately 1/2 and hour to 45 minutes after injection.   No respiratory symptoms at all,  urinary incontinence - History of some leakage but not bladder emptying -  x 2 an hour and an hour and a half after injection  I am a nurse, I relayed tachycardia to pharmacist  was given water  felt better and left after 30 minutes but symptoms persisted and chest tightness followed   and itching began I drove to urgent care and waited for them to pass with the plan that if they worsened or did not pass I would go in and be seen   After and hour and a half  I left to drive home, pulled over because of incontinence, continued home where my heart rate  ( usually 60 at rest ) remained in 70 to 80 range ( on fit bit and by pulse taking ) for another hour or so and then normalized and all symptoms resolved.
This case was reported by a healthcare professional via a sales representative and described the occurrence of  not responding to therapy in a 11-year-old male subject who was vaccinated with Hep B (manufacturer unspecified). Concurrent vaccination included Hib (manufacturer unspecified), PEDIARIX (GlaxoSmithKline), MMR (manufacturer unspecified) and VARIVAX (Merck) all given on 14 February 2002. On 14 February 2002 the infant subject received the final dose to complete the Hep B vaccination series at 0.5 ml in an unknown leg. Years later, at the age of 11, serology showed that the subject did not have protective antibodies. It was reported that the subject did not convert or had not responded to therapy. No additional details were provided. This event occurred in 4 separate subjects. Linked cases are A0941134A, A0941135A and A0941137A.
Patient experienced symptoms for 3 days following shot. She complained of extreme fatigue, body limp, and stayed in bed for a long time with extreme flu like symptoms She has chronic fatigue syndrome but she says that this was unlike what she had ever experienced
My daughter was given 2 vaccines in her first 24 hours of life. We were released from the hospital at hour 28 of life, and she died at home at hour 39, due to "unknown causes" which they later diagnosed as SUIDS.
pt recv vax & the day p/vax pt exp flu-like sx including h/a & aches;sx are resolving;
Having an allergic reaction; Arm has swelled up; Arm has a red patch that is getting bigger; It is like hive and itchy; It is like hive and itchy; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Having an allergic reaction), PERIPHERAL SWELLING (Arm has swelled up), ERYTHEMA (Arm has a red patch that is getting bigger), URTICARIA (It is like hive and itchy) and PRURITUS (It is like hive and itchy) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced HYPERSENSITIVITY (Having an allergic reaction), PERIPHERAL SWELLING (Arm has swelled up), ERYTHEMA (Arm has a red patch that is getting bigger), URTICARIA (It is like hive and itchy) and PRURITUS (It is like hive and itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, HYPERSENSITIVITY (Having an allergic reaction), PERIPHERAL SWELLING (Arm has swelled up), ERYTHEMA (Arm has a red patch that is getting bigger), URTICARIA (It is like hive and itchy) and PRURITUS (It is like hive and itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Mom called Nurse line and stated; " My daughter had a flu shot the other day. When she woke up this AM(11/05/2005)at about 9:30 AM, she was not responding. She raises her arm up and is just staring into space."
Well he got the shot at 9 in the morning and by 4 in the a.m he had a stoke and it took him 5 hrs to get to his phone for help and called my mother
tingling in foot; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in foot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 034F21A, 096812A and 02581A) for COVID-19 vaccination.     The patient's past medical history included Surgery (heart surgery) and Knee surgery NOS. Concurrent medical conditions included Prostatic cancer.   On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (tingling in foot). At the time of the report, PARAESTHESIA (tingling in foot) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 27Oct2022 at 17:00 as dose 5 (booster), single (Lot number: GS3275) at the age of 52 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 19Jan2021 at 15:30 as dose 1, single (Lot number: EL9261), in left arm, on 08Feb2021 at 09:30 as dose 2, single (Lot number: EM9810), in left arm, on 07Oct2021 at 16:00 as dose 3 (booster), single (Lot number: FF8839), in left arm and on 11Jun2022 at 11:30 as dose 4 (booster), single (Lot number: FM0173), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Tachycardia" (unspecified if ongoing); "massive bilateral pulmonary emboli" (unspecified if ongoing); "DVT from knee trauma, skiing" (unspecified if ongoing); "Allergic rhinitis" (unspecified if ongoing); "migraine (rare)" (unspecified if ongoing); "PENICILLINS ALLERGY" (unspecified if ongoing); "knee trauma" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received COVID 19 Treatment as Paxlovid with start date 30Jun2023 and stop date 05Jul2023.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300122487 same reporter/patient, different product/AE;
Site: Bruising at Injection Site-Mild, Site: Itching at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild
received a third dose; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 18-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included MENINGOCOCCAL B VACCINE (BEXSERO).   On 25th July 2022, the patient received the 3rd dose of Bexsero and Bexsero Pre-Filled Syringe Device. On 25th July 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 25-Jul-2022 Reporter's comment: The medical assistant reported a patient received a third dose of Bexsero a month apart from the second dose. The permission for storing personal information was declined.  The reporter contact information was sent by email to Safety. Additional supportive information: The patient received third dose of Bexsero, which led extra dose administered.
Clinical impression: benign paroxysmal position vertigo of the right ear. The doctor prescribed antivert for dizziness and Zopran ODT for nausea. Which I tried to take, but I cannot handle it. It make me  feel drowsy but I cannot sleep. I still feel dizzy when I lie down and when I turn my head laying down. I just take time to get out of bed. I never had vertigo before. This the first time I experienced vertigo.
almost blinded; He ended up with blurred vision; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  An 18-year-old male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Lot number: EW0168) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BLINDNESS (hospitalization), outcome "unknown", described as "almost blinded"; VISION BLURRED (hospitalization), outcome "unknown", described as "He ended up with blurred vision".
pt recvd vax & had red raised bumps on face & c/o itching to these areas;
This spontaneous report was received from a healthcare professional concerning a 18 month old male patient with no pertinent medical history nor drug reaction/allergies, who on 11-NOV-2013 was vaccinated with dose 1 of VAQTA (Lot No. J003719, exp. 27-SEP-2015), intramuscular for hepatitis A. On the same date the patient received a dose of diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (manufacturer unknown) and HIB conj vaccine (manufactured by Sanofi). Later the same date the patient's parent called the office and noted that the patient had significant hives. The patient received treatment with oral BENADRYL liquid. At the time of the report patient's outcome was unknown. Relationship between hives and therapy with VAQTA was not reported. Additional information has been requested.
Very swollen and sore under left arm pit and left breast area.  Stiff neck.  Started a little over 24 hours after injection.
Screaming for approx 15 minutes, paleness, lethargy, difficult to arouse from nap per mother, testicular swelling, temp to 100.4 R, went to ER and all SX had resolved, seen here next day and pt was fine.
I had a reaction that lasted 35-40 min, and started right after I got the vaccine shot. I had Elbow pain, chest pain, vision loss, and shortness of breath
Headache, Myalgia, Arthralgia, Fever, NauseaVomiting, chills, arm pain with redness and swelling Narrative:
Right upper arm swelling 24 hours after immunization. Local erythema, warmth, induration. No respiratory distress
Vaccine expired on 9/11/2022. Vaccine administered 9/12/2022 , expiration date not check before vaccine was administered.
patient developed hives, nausea, history of anaphylaxis, took her own 50mg Benadryl, EMS activated paramedics and took her to ER
Information has been received from a physician via medical recovered concerning a 2 month old male with exposure to GARDASIL (WAES #0807USA03843) and formula intolerance who on 19-FEB-2008 was vaccinated with the first dose of ROTATEQ (lot #657516/1128U). Concomitant therapy included PREVNAR, VERO, PEDIARIX, TRIHIBIT and TWINRIX. On 04-MAR-2008 office notes indicated that the patient had been trying different formulas to see which one he would tolerate the best however the rash seems to be little worse. He had an upper respiratory infection on approximately 01-MAR-2008 "last week" with some nebulizer treatments and seemed to improve however his riling and wheezing started again on 04-MAR-2008. Mild expiratory wheezes noted especially in the right upper lobe. The notes indicated that they would continue with the breathing treatments and continue to monitor the rash. They will continue to adjust formula until they find one he tolerates a little better. On 13-April-2008 the patient was vaccinated with the second dose of ROTATEQ (lot #660374/0275X). On 08-AUG-2008 the patient was vaccinated with the second dose ROTATEQ (lot #660845/0289X). On 08-AUG-2008 office notes indicated that the patient had a recent ear infection and was treated with AMOXIL BID. Additional information not expected.